The NIH’s funding opportunity (RFA-DA-25-072) seeks applications to develop and test new integrated models of care that combine HIV/AIDS treatment, addiction services, and primary care. This initiative aims to improve outcomes for patients affected by HIV and substance use disorders by creating streamlined, comprehensive care models. A clinical trial is required as part of this R01 grant.

Eligible applicants include a wide range of entities, such as state and local governments, higher education institutions, nonprofits, small businesses, and specific minority-serving institutions like HBCUs and Hispanic-serving Institutions. Foreign entities cannot apply directly, though foreign components can be included within U.S.-based projects.

There is no cost-sharing requirement for this opportunity. Applications are due by March 19, 2025, with an archiving date of April 24, 2025. Applicants can review the full details on the NIH website and contact NIH Grants Information for assistance. This grant is ideal for organizations focused on developing and evaluating integrated healthcare solutions to combat the HIV epidemic in populations with co-occurring addiction issues.